Standard treatment of chemotherapy-induced emesis

Supportive Care in Cancer

Volumn 5, Issue 1, 1997, Pages 12-16

  Warr, David ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Antiemetics; Chemotherapy; Guidelines

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOPAMINE RECEPTOR BLOCKING AGENT; DOXORUBICIN; FLUOROURACIL; GRANISETRON; METHOTREXATE; METOCLOPRAMIDE; METOPIMAZINE; ONDANSETRON; PROCHLORPERAZINE; SEROTONIN ANTAGONIST; TROPISETRON;

CANCER CHEMOTHERAPY; CLINICAL TRIAL; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VOMITING;

EID: 0030899544     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01681956     Document Type: Review

References (24)

1. Allan SG, Cornbleet MA, Warrington PS, Golland IM, Leonard RC, Smyth JN (1984) Dexamethasone and high dose metoclopramide: efficacy in controlling cisplatin induced nausea and vomiting. Br Med J 289:878-879
2. Beck TM, Hesketh PJ, Madajewicz S, et al (1992) Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting. J Clin Oncol 10:1969-1975
3. Berard CM, Mahoney CD (1995) Cost-reducing treatment algorithms for antineoplastic drug-induced nausea and vomiting. Am J Health Syst Pharm 52:1879-1885
4. Cognetti F, Pinnaro P, Carlini P, Caporali C, Ruggeri EM, Pollera CF (1984) Improved control of cisplatin-induced emesis with a metoclopramide-dexamethasone combination. Cancer Chemother Pharmacol 13:235-237
5. Dranitsaris G, Warr D, Puodziunas A (1995) A randomized trial of the effects of pharmacist intervention on the cost of antiemetic therapy with ondansetron. Support Care Cancer 3:183-189
6. Herrstedt J, Sigsgaard T, Handberg J, Hansen M, Dombernowsky P (1994) Randomized, double-blind cross-over trial of the antiemetic effect and tolerability of ondansetron (OND) vs OND plus the dopamine D2 receptor antagonist metopimazine (MPZ) in patients (PTS) receiving platinum-based chemotherapy (CT) (abstract). Proc Am Soc Clin Oncol 13:443
7. Italian Group for Antiemetic Research (1992) Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cispiatin-induced emesis. Lancet 340:96-99
8. Italian Group for Antiemetic Research (1995) Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. N Engl J Med 332:1-5
9. Kaizer L, Warr D, Hoskins P, et al (1994) Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderatelv emetogenic chemotherapy: a phase III trial by the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 12:1050-1057
10. Kris MG, Gralla RJ, Tyson LB, Clark RA, Cirrincione C, Groshen S (1989) Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. J Clin Oncol 7:108-114
11. Latreille J, Stewart D, Laberge F, et al (1995) Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy. Support Care Cancer 3:307-312
12. Latreille J, Johnston D, Laberge F, et al (1995) Use of granisetron and dexamethasone on days 2-7 following high dose cisplatin (abstract). Support Care Cancer 3:339
13. Levin M, Warr D, Yelle L, et al (1993) A comparison of ondansetron versus dexamethasone and metoclopramide in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and 5-flurouracil, a study by the Clinical Trials Group of the National Cancer Institute of Canada. N Engl J Med 328:1081-1084
14. Lofters W, Zee B (1995) Adding 5-HT; receptor antagonists to dexamethasone after twenty-four hours has a minimal effect in preventing delayed onset nausea and vomiting in patients receiving moderately ometogenic chemotherapy (abstract). Support Care Cancer 3:339
15. Navari RM, Madajewicz S, Anderson N, et al (1995) Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo. J Clin Oncol 13:2408-2416
16. Ninane J, Ozkaynak MF, Kurtin P, Stegel SE (1995) Variation in the use of ondansetron as an antiemetic drug in children treated with chemotherapy. Med Pediatr Oncol 25:33-37
17. Osoba D, Warr DG, Fitch MI, Nakashima L, Warren B (1995) Guidelines for the optimal management of chemotherapy-induced nausea and vomitins: a consensus. Can J Oncol 5:381-400
18. Pater J, Slamet L, Zee B, Osoba D, Warr D, Rusthoven J (1994) Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting. Support Care Cancer 2:161-166
19. Ruff P, Paska W, Goedhals L, et al (1994) Ondansetron compared with granisetron in the prophylaxis of cisplatin-induced acute emesis: a multicentre double-blind, randomised, parallel-group study. The Ondansetron and Granisetron Emesis Study Group. Oncology 51:113-118
20. Seynaeve C, Schuller J, Buser K, et al (1992) Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis - a multicentre, double-blind, randomised, parallel group study. Br J Cancer 66:192-197
21. Silvey L, Carpenter JT Jr, Wheeler RH. Lee J, Conolley C (1988) A randomized comparison of haloperidol plus dexamethasone versus prochlorperazine plus dexamethasone in preventing nausea and vomiting in patients receiving chemotherapy for breast cancer. J Clin Oncol 6:1397-1400
22. Smith DB, Newlands ES, Rustin GJS, et al (1991) Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet 338:487-490
23. Vermeulen LC Jr, Matuszewski KA, Ratko TA, Butler CD, Burnett DA, Vlasses PH (1994) Evaluation of ondansetron prescribing in US academic medical centers. Arch Intern Med 154:1733-1740
24. Warr D, Willan A, Fine S, et al (1991) Superiority of granisetron to dexamethasone plus prochlorperazine in the prevention of chemotherapy-induced emesis. J Natl Cancer Inst 83:1169-1173